BOSTON (MedPage Today) -- A biologic drug targeting the granulocyte-macrophage colony stimulating factor was safe and showed hints of activity against brain lesions in multiple sclerosis patients in a phase I trial. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment